Clinical Effect of Norepinephrine Combined with Esmolol Treatment in Patients with Septic Shock and Its Impact on Prognosis: A Retrospective Study

Read full text Summarise with VIRAT
Authors: Sameechi M., Manjunath Irappa Pattanshetti, Chirag M. Gowda
Cited by: 0
References: 5

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Septic shock is linked to elevated mortality and is defined by significant circulatory and metabolic dysfunctions. Norepinephrine is the primary vasopressor; however, sustained tachycardia may exacerbate results. Esmolol, a short-acting β1-adrenergic antagonist, has been suggested to enhance hemodynamic and prognosis. Objective: To assess the therapeutic efficacy of norepinephrine in conjunction with esmolol in patients experiencing septic shock and its influence on in-hospital outcomes. Methods: This retrospective analysis encompassed 100 individuals diagnosed with septic shock over a two-year period. Patients were categorized into two groups: Group A (n=50) was administered norepinephrine only, while Group B (n=50) got a combination of norepinephrine and esmolol. Hemodynamic parameters, lactate clearance, vasopressor requirements, duration of ICU stay, and in-hospital mortality were analysed for comparison. Results: The combination group showed significantly improved mean arterial pressure (MAP) at 24 hours (75 ± 8 mmHg vs 62 ± 10 mmHg, p

Fields of Study & Subjects

Sepsis Diagnosis and Treatment Hemodynamic Monitoring and Therapy Abdominal Surgery and Complications

Publication details

Journal / source
International Journal of Current Pharmaceutical Review and Research
Volume
18
Issue
01
Publication date
30 January 2026
Language
EN